These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 567044)

  • 1. Inhibition of apomorphine-induced behaviors by derivatives of 2-amino-1, 2, 3, 4-tetrahydronaphthalene.
    Rusterholz DB; Long JP; Flynn JR; Glyn JR; Barfknecht CF; Lind RW; Johnson AK
    Arch Int Pharmacodyn Ther; 1978 Apr; 232(2):246-60. PubMed ID: 567044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic activity of some apomorphine analogs.
    Cheng HC; Long JP; Van Orden LS; Cannon JG; O'Donnell JP
    Res Commun Chem Pathol Pharmacol; 1976 Sep; 15(1):89-106. PubMed ID: 968179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of stimulation and destruction of the substantia nigra on phenamine- and apomorphine-induced stereotypy in cats].
    Tolpyshev BA; Sergeev MV
    Farmakol Toksikol; 1981; 44(5):550-4. PubMed ID: 7198053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lesions of substantia nigra by kainic acid: effects on apomorphine-induced stereotyped behaviour.
    Morelli M; Porceddu ML; Di Chiara G
    Brain Res; 1980 Jun; 191(1):67-78. PubMed ID: 7189684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacological investigation of rotational behaviors produced by unilateral electrical stimulation of the substantia nigra in the rat].
    Watanabe H; Hata S; Watanabe K
    Nihon Yakurigaku Zasshi; 1983 Oct; 82(4):247-57. PubMed ID: 6141127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of alpha-2 adrenoceptor agonists and antagonists on circling behavior in rats with unilateral 6-hydroxydopamine lesions of the nigrostriatal pathway.
    Chopin P; Colpaert FC; Marien M
    J Pharmacol Exp Ther; 1999 Feb; 288(2):798-804. PubMed ID: 9918591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of lesioning both the superior colliculus and the substantia nigra of cats on turning behavior.
    Motles E; Saavedra H; Leiva J; Infante C
    Arch Ital Biol; 1991 Jun; 129(3):211-22. PubMed ID: 1929706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Penfluridol blockade of apomorphine: dependence of duration on species and endpoint.
    Weissman A
    Eur J Pharmacol; 1975; 33(2):267-75. PubMed ID: 1237408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the sympathetic nervous system by 5,6-dihydroxy-2-dimethylamino tetralin (M-7), apomorphine and dopamine.
    Long JP; Heintz S; Cannon JG; Kim J
    J Pharmacol Exp Ther; 1975 Feb; 192(2):336-42. PubMed ID: 1117421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of acute L-Dopa pretreatment on apomorphine-induced rotational behavior in a rat model of Parkinson's disease.
    Mandel RJ
    Exp Neurol; 2000 Jan; 161(1):212-9. PubMed ID: 10683287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and biological actions of some symmetrically N,N-disubstituted dopamines.
    Cannon JG; Hsu FL; Long JP; Flynn JR; Costall B; Naylor RJ
    J Med Chem; 1978 Mar; 21(3):248-53. PubMed ID: 564406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose related sequence of effects induced by the DA agonist 2-(N,N-dipropyl)-amino-5,6-dihydroxytetralin.
    Doaré L; Puech AJ; Simon P
    J Pharmacol; 1986; 17(1):60-4. PubMed ID: 3713199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Behavioral evaluation of the unilateral lesion model in rats using 6-hydroxydopamine. Correlation between the rotations induced by D-amphetamine, apomorphine and the manual dexterity test].
    Pavón N; Vidal L; Alvarez P; Blanco L; Torres A; Rodríguez A; Macías R
    Rev Neurol; 1998 Jun; 26(154):915-8. PubMed ID: 9658459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioural correlates to the dopamine D-1 and D-2 antagonists.
    Christensen AV; Arnt J; Hyttel J; Svendsen O
    Pol J Pharmacol Pharm; 1984; 36(2-3):249-64. PubMed ID: 6147830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pharmacological comparison of 6,7-dihydroxy-2-dimethylaminotetralin (TL-99) and N-n-propyl-3-(3-hydroxyphenyl)piperidine with (3-PPP) selected dopamine agonists.
    Martin GE; Williams M; Haubrich DR
    J Pharmacol Exp Ther; 1982 Nov; 223(2):298-304. PubMed ID: 6813451
    [No Abstract]   [Full Text] [Related]  

  • 16. Dopaminergic antagonists: effects of 1,2,3,4-tetrahydroisoquinoline and its N-methyl and N-propyl homologs on apomorphine- and L-dopa-induced behavioral effects in rodents.
    Ginos JZ; Doroski D
    J Pharmacol Exp Ther; 1979 Apr; 209(1):79-86. PubMed ID: 571017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological profile of N,N dipropyl-8-hydroxy-3-chromanamine, an oxygen isostere of the dopamine agonist N,N dipropyl-5-hydroxy-2-aminotetralin with enhanced presynaptic selectivity.
    Vermue NA; Kaptein B; Tepper PG; de Vries JB; Horn AS
    Arch Int Pharmacodyn Ther; 1988; 293():37-56. PubMed ID: 3421784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of lergotrile or apomorphine induced turning behavior by haloperidol and clozapine.
    Nakamura S; Engel J; Goldstein M
    Commun Psychopharmacol; 1978; 2(3):185-90. PubMed ID: 29742
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of alpha-adrenergic receptor stimulant drugs on amphetamine or apomorphine-induced stereotypy in rats.
    Zebrowska-Lupina I; Kleinrok Z; Kozyrska C; Wielosz M
    Pol J Pharmacol Pharm; 1978; 30(4):459-67. PubMed ID: 33370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RDS-127 (2-di-n-propylamino-4,7-dimethoxyindane): central effects of a new dopamine receptor agonist.
    Arnerić SP; Long JP; Williams M; Goodale DB; Mott J; Lakoski JM; Gebhart GF
    J Pharmacol Exp Ther; 1983 Jan; 224(1):161-70. PubMed ID: 6401334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.